Adams Diversified Equity Fund’s Novartis NVS Stock Holding History

Adams Diversified Equity Fund’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-197,532	Closed	-$15.2M	–	82
2015 Q4	$15.2M	Sell	197,532 -69,192	-26%	-$5.5M	1.05%	43
2015 Q3	$22M	Hold	266,724	–	–	1.58%	22
2015 Q2	$23.5M	Hold	266,724	–	–	1.55%	20
2015 Q1	$23.6M	Buy	+266,724	New	+$23.7M	1.55%	21

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Institutional Capital Chicago, Illinois $6.75B AUM 3.51% 1-Year Est. Return

Adams Diversified Equity Fund's NVS Position: Q1 2016 in Review

Adams Diversified Equity Fund sold out of Novartis (NVS) in Q1 2016, closing a stake of 197,532 shares — an estimated $15.2M sold.

Adams Diversified Equity Fund first reported a position in NVS in Q1 2015 and held it in 4 quarters. The position peaked at $23.6M in Q1 2015. 876 funds tracked by Wall St. Rank hold NVS as of Q1 2016.

Adams Diversified Equity Fund reported no remaining Novartis position as of Q1 2016 after selling out during the quarter.
Adams Diversified Equity Fund sold 197,532 Novartis shares in Q1 2016, an estimated $15.2M.
Adams Diversified Equity Fund first reported a position in Novartis in Q1 2015 and held it in 4 quarters.
Adams Diversified Equity Fund's Novartis position peaked at $23.6M in Q1 2015.
876 funds tracked by Wall St. Rank held Novartis as of Q1 2016.

Based on Adams Diversified Equity Fund's 13F filing for Q1 2016, filed 25 Apr 2016.